What the rollout of Covid-19 shots for ages 5 to 11 might look like
Vaccine makers Pfizer and BioNTech announced last week that they have submitted Covid-19 vaccine data on children ages 5 to 11 to the FDA for initial review.
Stay updated with breaking news from Immunization Managers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccine makers Pfizer and BioNTech announced last week that they have submitted Covid-19 vaccine data on children ages 5 to 11 to the FDA for initial review.
As soon as the US Food and Drug Administration authorizes the Pfizer/BioNTech coronavirus vaccine for children ages 5 to 11 in the United States, pediatricians' offices, local pharmacies and even
Pediatricians, pharmacies and schools could begin administering COVID-19 shots to kids if they receive emergency authorization from the U.S. Food and Drug Administration.
Pediatricians, pharmacies and schools could begin administering COVID-19 shots to kids if they receive emergency authorization from the U.S. Food and Drug Administration.
Pediatricians, pharmacies and schools could begin administering COVID-19 shots to kids if they receive emergency authorization from the U.S. Food and Drug Administration.